INTRODUCTION
Human mast cells, unlike those of rodent origin, cannot be supported in IL-3 but rather have an apparent obligatory requirement for stem cell factor (SCF). The ability of other growth factors to influence SCF-dependent mast cell cultures has focused on Th1 and Th2 cytokines because mast cells play a key role in allergic diseases and may facilitate Th1 inflammation. Th1 cytokines are generally thought to inhibit, while Th2 cytokines are reported to enhance, human mast cell number and responsiveness although the results are inconsistent. IL-4 has been stated to increase human intestinal mast cell number 1 and to decrease 2 , increase 3 or have no effect 4 on human cord blood mast cells.
IL-4 is also reported to induce apoptosis of immature mast cell progenitors 2 and to have no effect on mast cells grown from human bone marrow. 5 IL-5 has been reported to prolong survival of cord blood derived mast cells after withdrawal of SCF. 6 IL-5 has also been shown to slightly inhibit growth of an actively dividing SCF-dependent human mast cell line. 7 The few reports on the effects of interferon-(IFN-) on human mast cells
show that IFN-decreases [ 3 H]thymidine incorporation by cord blood derived mast cells 3 and inhibits mast cell growth from human bone marrow. 8 It is unclear whether IFNinhibits cell division or induces apoptosis of mast cell progenitors.
Because of these inconsistencies, we hypothesized that there are cytokine-specific effects on SCF dependent mast cell cultures and that such effects vary depending upon whether exposure to a given cytokine occurs as cultures develop and thus exerts its effects on mast cell development, or is added to cultures of differentiated mast cells. We thus chose to examine the effects of IFN-, IL-4 and IL-5 on human mast cells derived from CD34 + peripheral blood under identical conditions and over the duration of culture
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From page:5 or when added to mature mast cells. To directly examine cell division, we employed carboxyfluorescein succinimidyl ester (CFSE) dye for high resolution cell tracking, and simultaneously examined the kinetics of apoptosis and Kit expression. The data to be presented demonstrates that these cytokines added throughout the duration of culture inhibit mast cell number, albeit by different mechanisms. Only IL-4 was capable of affecting cell division and enhancing degranulation of mature mast cells. Such data is critical in anticipating the effects of cytokine manipulation on mast cell function, and is sometimes counter-intuitive in that, for instance, IL-4 which potentiates Th2 responses, also inhibits mast cell growth if added throughout the process of mast cell proliferation and maturation.
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MATERIALS AND METHODS

Materials and antibodies
Anti
Human mast cell culture and cell counts
Human peripheral blood CD34 + progenitor cells were collected from normal donors following informed consent and processed via affinity column apheresis. CD34 + cells were seeded at a density of 10 5 cells/ml in serum free media (StemPro-34 SFM, Life
Technologies, Grand Island, NY) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 50 µg/ml streptomycin and 100 ng/ml SCF. Some cultures also contained 10 ng/ml IFN-, 10 ng/ml IL-4, or 10 ng/ml IL-5. Concentration of cytokine was selected to agree with previous studies. 3, 4, 8, 9 All cultures were maintained at 37 o C and 5% CO2.
Half of the cytokine-supplemented medium was replaced weekly and cells transferred to The -hexosaminidase in the supernatants and cell lysates was Tryptase content in cell-free supernatants was measured using a colorimetric assay as described. 13 Briefly, 50 µl of mast cell supernatants were mixed with 100 µl of 0.8 mM benzoyl-DL-arginine-p-nitroaniline (BAPNA) in Tris buffer (0.1 M Tris/ 1M glycerol, pH 7.8) and incubated for 4 hr at 37 o C. The appearance of nitroaniline was measured at 410 nm. To quantitate tryptase, samples were compared to a standard curve obtained using purified lung tryptase (Cortex Biochem, San Leandro, CA). 
Statistical analysis
IFN-, IL-4 and IL-5 decrease cell number in peripheral blood CD34+ cultures
To determine the effect of IFN-, IL-4 and IL-5 on total cell number and the number of mast cells observed when each was present throughout culture, CD34 + progenitors were purified from human peripheral blood and 1 x 10 6 cells were cultured in serum-free growth media containing SCF (100 ng/ml) and IFN-(10 ng/ml), IL-4 (10 ng/ml) or IL-5 (10 ng/ml). Each week, total cells were counted and an aliquot was stained with toluidine blue to determine mast cell number. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From page:13 inhibited both total and mast cell numbers in culture, it seemed to preserve expression of CD34.
Cell division -2 to 8 weeks
At the end of week one of culture, cell numbers were increasing under all conditions, after which, during week one to two, cells rapidly increased in number, then decreased to a cell number that roughly remained constant to 8 weeks. It was during this later plateau phase that mast cells could be clearly identified at 3-4 weeks. To examine the complex dynamics of cultures during this period, we analyzed cell division sequentially over one week time periods -by adding CFSE at the beginning of the time period and measuring division over the next 7 days.
Since dividing cells become increasingly autofluorescent as they mature, the coefficient of variation within each fluorescent peak increases and statistical software was used to account for such variations and mathematically calculate each division Cell division in each subsequent week of culture was similarly determined. This data over 8 weeks of culture was pooled and is represented in Table 1 . Ninety-five percent of the cells grown in SCF alone divided giving rise to at least 19 generations, or 18 divisions over the entire 8 week period. However, only 56 % of the cells grown in 
Apoptosis -1 to 8 weeks
Because cells continued to divide under all conditions, the stabilization of cell numbers after two weeks would best be explained by concurrent cell death. We thus determined the percent of cells undergoing apoptosis through 8 weeks. As can be seen in Fig 3B, the number of cells undergoing apoptosis dramatically increased between one and two weeks. The continued high rate of apoptosis through 7 weeks of culture is the most likely explanation for overall cell numbers remaining constant in the face of demonstrable proliferation (see Table 1 ). The highest rate of apoptosis is seen in cultures containing IFN-or IL-4, again consistent with the observed effect of IFN-and IL-4 on cell number as seen in Fig 2A. Further, in every instance, the number of apoptotic cells 
Toluidine blue staining revealed that cells cultured in SCF+IFN-contained few granules and were smaller than cells cultured in SCF alone (Fig. 4D) . Cells grown in IL-4 were also smaller but contained some granules (Fig. 4D) . More than 90 % of cells cultured in SCF+IL-5 were toluidine blue positive and were morphologically similar to cells cultured in SCF alone (Fig. 4D) . Cells cultured in SCF alone contained approximately 4.3 + 0.6 pg of histamine per cell (Fig. 4E) Table 2 .
IL-4 potentiates division of mature mast cells and mast cell degranulation
Having examined the effect of cytokines on mast cell development throughout 8 weeks of culture, we next determined the effect of these cytokines when first added to mature mast cell cultures at 8 weeks. It has been reported that IL-4 potentiates mediator release and cell division when added later to mast cell cultures. 9 To test the effect of (Fig. 5A) . Concurrent flow cytometry analysis of Kit expression showed the IL-4 had no effect on Kit expression (data not shown).
To examine releasability, 8 week old mast cells pretreated with SCF, SCF+IFN-, SCF+IL-4 and SCF+IL-5 for seven days were sensitized with IgE, stimulated with antigen, and -hexosaminidase release was measured (Fig 5B) . Although IFN-and IL-5 had no effect on human mast cell mediator release, IL-4 potentiated spontaneous as well as antigen-stimulated -hexosaminidase release by about approximately 40 % (Fig. 5B) .
The increase in releasability seen in cultures exposed to IL-4 was accompanied by an increase in Fc RI expression consistent with previous reports (data not shown; 14 ) . Thus, of the Th1 and Th2 cytokines examined, IL-4 was one cytokine that clearly enhanced mast cell function when added for the first time late in cultures. The studies presented in this paper clarify the basis for the reports on the effect of IL-4 on mast cells that variously describe it as potentiating or inhibiting mast cell function.
2-4,9,15 Clearly, IL-4 when added throughout the process of mast cell growth and differentiation inhibits SCF-dependent cell division (Table 1) and decreases final mast cell numbers (Fig 2) . IL-4 further changes the mast cell phenotype in that mast cells cultured in the presence of IL-4 were smaller in size, expressed 50% less kit, and released less granule associated enzymes when activated through Fc RI (Fig 4B) . This is in marked contrast to the effect of IL-4 when added to a later culture containing differentiated mast cells. Here, IL-4 was unique among the cytokines examined in stimulating further mast cell division (Fig 5A) , upregulating Fc RI (data not shown) and potentiating mast cell degranulation (Fig 5B) . This data clearly establishes that it cannot be assumed that a Th2 cytokine will under various conditions always enhance mast cell function and further underscores the importance of IL-4 in potentiating mast cell function of mature mast cells.
IFN-has been reported to inhibit mast cell outgrowth in cultures if present throughout the period of culture. Our data is consistent with these observations. We
For
found that IFN-inhibits mast cell numbers, influences mast cell phenotype, and the few hypo-granular, small mast cells that remain release little granule mediators after receptor aggregation (Fig 4) . However, the effect of IFN-on mature mast cells was unexpected.
Here, IFN-had relatively little effect (Fig 5) even though mature mast cells expressed IFN-R (Fig 1) . This observation, however, could mean that mast cell function could be expected to be maintained in type I inflammation as others have suggested. + progenitors within the first week of culture ( Fig 2C) and subsequently promoted the apoptosis of older Kit + cells (Fig 3B) . Specifically, IFNinhibited division of a CD34 + /Kit low subpopulation in the first week of culture and blocked all cell division at 2 weeks of culture. Whereas it has been shown that mature 9-week-old cord blood derived mast cells incorporate a substantial amount of thymidine in response to SCF 3 , CFSE measurements showed that mature 8-week-old peripheral bloodderived human mast cell divided only once in 7 days in response to SCF (Fig 5A) . This may explain why mature cord blood derived mast cell SCF-driven proliferation is inhibited by IFN-but mature peripheral blood derived mast cell proliferation is not.
Therefore, IFN-inhibited peripheral blood derived mast cell growth primarily by blocking early cell division.
In contrast to IFN-, IL-4 inhibited mast cell differentiation and survival by decreasing early Kit expression and promoted an immature CD34 + phenotype. Some reports have suggested that IL-4 has an opposing effect on human mast cells, depending on their source and age. For example, IL-4 promotes SCF-driven proliferation of 4-week-old cord blood derived mast cells but has no affect on 9-10-week-old cord blood derived mast cells. [2] [3] [4] Yet, IL-4 enhances SCF-driven proliferation of intestinal mast cells. 20 We have also observed the differential effects of IL-4 on progenitor and mature mast cells since IL-4 inhibited early progenitor division but promoted division of 8 weekold mast cells (Fig 3A) . These differential effects were apparently mediated by decreasing Kit expression, since IL-4 decreased Kit expression of CD34 + progenitors ( Fig   2D) but had no affect on mature mast cell Kit expression (data not shown).
There is an increasing appreciation of the biologic role of mast cells in both Th1
and Th2 dependent inflammation. The data presented in this paper clearly show that the behavior and characteristics of mast cells are altered when they are exposed to IFN-or IL-4. When IFN-and IL-4 are continuously present during mast cell development, both cytokines lead to a decrease in mast cell number and mast cell releasability although here the effect of IFN-is more dramatic. If mast cells are of benefit to both inducing 21, 22 and resolving 23 inflammation then the loss of mast cell function in chronic inflammation, no matter whether Th1 or Th2 dependent, might be considered to be particularly detrimental to the host and raises the possibility that strategies to increase mast cell number and function in chronic inflammation may be paradoxically beneficial. This is in contrast to with mild to moderate asthma. 25 In this instance, the effect maybe on mature tissue mast cells and decrease their proliferation. Similarly, IFN-has been shown to inhibit pulmonary allergic responses. 26 These effects of IFN-may be mediated, in part, by a decrease in mast cell numbers consistent with the data presented herein. There is some evidence to suggest that recombinant human IFN-may similarly decrease mast cell numbers in patients with mastocytosis although these patients often relapse because of anti-rhIFN-production. 27 The multitechnical approach applied in this report, including high resolution tracking of cell division, thus appears to yield data that anticipate possible outcomes of in vivo strategies that manipulate the effects and/or levels of cytokines, and in situations where results may differ from the simple concept that Th1 cytokines down-regulate Th2 inflammation, while Th2 cytokines potentiate such a response.
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